Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | HMGCR | P04035 | 1/20 | 0.30 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.30 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.30 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL10701836 | 0.81 | TDP1 (0.42) | TDP1GABRR1LMNASLC22A6KDM4E | |
| SCHEMBL271763 | 0.78 | TDP1 (0.39) | TDP1GABRR1LMNASLC22A6KDM4E | |
| SCHEMBL3336391 | 0.78 | TDP1 (0.39) | TDP1GABRR1LMNASLC22A6KDM4E | |
| SCHEMBL9805121 | 0.77 | TDP1 (0.37) | TDP1GABRR1LMNASLC22A6KDM4E | |
| SCHEMBL750130 | 0.73 | TDP1 (0.42) | TDP1GABRR1LMNASLC22A6KDM4E | |
| SCHEMBL7999396 | 0.71 | TDP1 (0.40) | TDP1GABRR1LMNASLC22A6KDM4E | |
| SCHEMBL396503 | 0.71 | TDP1 (0.40) | TDP1GABRR1LMNASLC22A6KDM4E | |
| SCHEMBL2491274 | 0.71 | SLC22A6 (0.50) | TDP1GABRR1LMNASLC22A6SMN1; SMN2 | |
| Water SCHEMBL7227622 | 0.69 | SLC22A6 (0.47) | TDP1GABRR1LMNASLC22A6SMN1; SMN2 | |
| Ammonia Solution, Strong SCHEMBL11416138 | 0.68 | LMNA (0.43) | TDP1GABRR1LMNASLC22A6KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060155107-A1 | SSTR1-selective analogs | THE SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) | 2006-07-13 | — | — | US | disclosed |
| US-7019109-B2 | Cyclic somatostatin for use in the treatment and prevention of tumor propagation | THE SALK INSTITUTE FOR BILOGICAL STUDIES (US) | 2006-03-28 | — | — | US | disclosed |
| EP-0733060-B1 | METAL CHELATORS | BRACCO INT BV (NL) | 2005-05-25 | — | — | EP | disclosed |
| US-20020173618-A1 | SSTR1-selective analogs | SALK INSTITUTE OF BIOLOGICAL STUDIES, THE | 2002-11-21 | — | — | US | disclosed |
| US-6274118-B1 | INJECTING PATIENT HAVING ENDOCRINE CANCER IN NON-PROSTATIC TISSUE WITH BIOLOGICAL BINDING UNITS WHICH BIND TO PROSTATE SPECIFIC ANTIGEN PRODUCED BY NON-PROSTATIC TISSUE | NORDION INTERNATIONAL INC. (CA) | 2001-08-14 | — | — | US | disclosed |
| EP-0772628-B1 | PEPTIDE DERIVED RADIONUCLIDE CHELATORS | RESOLUTION PHARM INC (CA) | 2000-07-19 | — | — | EP | disclosed |
| US-6068830-A | IN VIVO METHOD FOR IMAGING BREAST AND OVARIAN CANCERS IN NON-PROSTATIC TISSUE OF A PATIENT | NORDION INTERNATIONAL INC. (CA) | 2000-05-30 | — | — | US | disclosed |
| US-5976495-A | Peptide derived radionuclide chelators | RESOLUTION PHARMACEUTICALS, INC. (CA) | 1999-11-02 | — | — | US | disclosed |
| EP-0716647-B1 | HYDRAZINO-TYPE N2S2 CHELATORS | RESOLUTION PHARM INC (CA) | 1999-03-24 | — | — | EP | disclosed |
| US-5858327-A | CONJUGATION TO TARGETTING AND LABELLING BIOMOLECULES LIKE PROTEINS, PEPTIDES AND ANTIBODIES; CONTRAST AGENTS FOR TOMAGRAPHY DIAGNOSIS | RESOLUTIONS PHARMACEUTICALS, INC. (CA) | 1999-01-12 | — | — | US | disclosed |
| US-5659041-A | MEDICAL DIAGNOSIS, THERAPY | RESOLUTION PHARMACEUTICALS, INC. (CA) | 1997-08-19 | — | — | US | disclosed |
| EP-0772628-A1 | PEPTIDE DERIVED RADIONUCLIDE CHELATORS | RESOLUTION PHARMACEUTICALS INC. (CA) | 1997-05-14 | — | — | EP | disclosed |
| US-5574140-A | LABELS FOR TARGETS MOLECULES FOR DIAGNOSIS | RESOLUTION PHARMACEUTICAL INC. (CA) | 1996-11-12 | — | — | US | disclosed |
| EP-0733060-A1 | METAL CHELATORS | RESOLUTION PHARMACEUTICALS INC. (CA) | 1996-09-25 | — | — | EP | disclosed |
| EP-0710228-A1 | HYDRAZINO-TYPE RADIONUCLIDE CHELATORS HAVING AN N 3?S CONFIGURATION | RESOLUTION PHARMACEUTICALS INC. (CA) | 1996-05-08 | — | — | EP | disclosed |
| WO-1996003427-A1 | PEPTIDE DERIVED RADIONUCLIDE CHELATORS | RESOLUTION PHARMACEUTICALS INC. (CA) | 1996-02-08 | — | — | WO | disclosed |
| US-5480970-A | RADIOACTIVE MATERIALS FOR LABELS IN DIAGNOSIS OF TUMORS IN TISSUES | RESOLUTION PHARMACEUTICALS (CA) | 1996-01-02 | — | — | US | disclosed |
| WO-1995017419-A1 | METAL CHELATORS | RESOLUTION PHARMACEUTICALS INC. (CA) | 1995-06-29 | — | — | WO | disclosed |
| WO-1995003280-A1 | HYDRAZINO-TYPE RADIONUCLIDE CHELATORS HAVING AN N3S CONFIGURATION | RESOLUTION PHARMACEUTICALS INC. (CA) | 1995-02-02 | — | — | WO | disclosed |
| WO-1995002424-A1 | LOCALIZATION AND THERAPY OF NON-PROSTATIC ENDOCRINE CANCER WITH AGENTS DIRECTED AGAINST PROSTATE SPECIFIC ANTIGEN | NORDION INTERNATIONAL INC. (CA) | 1995-01-26 | — | — | WO | disclosed |